[ad_1] (Reuters) – Bristol-Myers Squibb Co said on Friday that its flagship cancer drug, Opdivo, was not reaching the main goal of an advanced phase-out trial on patients suffering from cancer. a …
Read More »Opdivo Bristol-Myers does not reach the goal of the lung cancer study
